OS Therapies, Inc. (OSTX) SEC Filings https://ir.ostherapies.com/sec-filings/all-sec-filings/rss OS Therapies, Inc. (OSTX) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/ostherapies/files/theme/images/logo-sm-2x.png OS Therapies, Inc. Logo Equisolve Investor Relations Suite <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-090238/0001213900-26-090238.pdf Fri, 14 Aug 26 17:04:58 -0400 https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-090238/0001213900-26-090238.pdf <![CDATA[8-K - Current report]]> https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-088435/0001213900-26-088435.pdf Wed, 12 Aug 26 16:56:40 -0400 https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-088435/0001213900-26-088435.pdf <![CDATA[8-K - Current report]]> https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-086150/0001213900-26-086150.pdf Thu, 06 Aug 26 16:18:32 -0400 https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-086150/0001213900-26-086150.pdf <![CDATA[424B5 - Prospectus [Rule 424(b)(5)]]]> https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-086149/0001213900-26-086149.pdf Thu, 06 Aug 26 16:18:25 -0400 https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-086149/0001213900-26-086149.pdf <![CDATA[8-K - Current report]]> https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-082876/0001213900-26-082876.pdf Wed, 29 Jul 26 17:01:30 -0400 https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-082876/0001213900-26-082876.pdf <![CDATA[ARS - Annual Report to Security Holders]]> https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-081423/0001213900-26-081423.pdf Fri, 24 Jul 26 16:37:32 -0400 https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-081423/0001213900-26-081423.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-081417/0001213900-26-081417.pdf Fri, 24 Jul 26 16:33:40 -0400 https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-081417/0001213900-26-081417.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-081390/0001213900-26-081390.pdf Fri, 24 Jul 26 16:18:04 -0400 https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-081390/0001213900-26-081390.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-080878/0001213900-26-080878.pdf Thu, 23 Jul 26 16:17:14 -0400 https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001213900-26-080878/0001213900-26-080878.pdf <![CDATA[D - Notice of Exempt Offering of Securities]]> https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001795091-26-000003/0001795091-26-000003.pdf Thu, 16 Jul 26 06:03:38 -0400 https://ir.ostherapies.com/sec-filings/all-sec-filings/content/0001795091-26-000003/0001795091-26-000003.pdf